Analysis of a nonlinear free-boundary tumor model with angiogenesis and
  a connection between the nonnecrotic and necrotic phases by Song, Huijuan et al.
ar
X
iv
:2
00
8.
08
77
0v
1 
 [m
ath
.A
P]
  2
0 A
ug
 20
20 Analysis of a nonlinear free-boundary tumor model
with angiogenesis and a connection between the
nonnecrotic and necrotic phases
Huijuan Song, Wentao Hu, Zejia Wang∗
School of Mathematics and Statistics, Jiangxi Normal University,
Nanchang, Jiangxi 330022, PR China
Abstract
This paper is concerned with a nonlinear free boundary problem modeling the growth
of spherically symmetric tumors with angiogenesis, set with a Robin boundary condition.
In which, both nonnecrotic tumors and necrotic tumors are taken into consideration. The
well-posedness and asymptotic behavior of solutions are studied. It is shown that there exist
two thresholds, denoted by σ˜ and σ∗, on the surrounding nutrient concentration σ¯. If σ¯ ≤ σ˜,
then the considered problem admits no stationary solution and all evolutionary tumors will
finally vanish, while if σ¯ > σ˜, then it admits a unique stationary solution and all evolutionary
tumors will converge to this dormant tumor; moreover, the dormant tumor is nonnecrotic
if σ˜ < σ¯ ≤ σ∗ and necrotic if σ¯ > σ∗. The connection and mutual transition between the
nonnecrotic and necrotic phases are also given.
Keywords: Free boundary problem; nonnecrotic and necrotic tumors; angiogenesis; sta-
bility; connection
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1 Introduction
In this paper, we study the following nonlinear free boundary problem modeling the growth
of spherically symmetric tumors with angiogenesis:
1
r2
∂
∂r
(
r2
∂σ
∂r
)
= f(σ)H(σ − σD) for 0 < r < R(t), t > 0, (1.1)
∂σ
∂r
(0, t) = 0 for t > 0, (1.2)
∂σ
∂r
(R(t), t) + β[σ(R(t), t) − σ¯] = 0 for t > 0, (1.3)
R2(t)
dR
dt
=
∫
σ>σD
g(σ)r2 dr −
∫
σ≤σD
νr2 dr for t > 0, (1.4)
R(0) = R0, (1.5)
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where σ(r, t) is the nutrient concentration in the tumor, r = |x|, x ∈ R3, and R(t) is the radius
of the tumor at time t, which are both unknown and need to be determined together, H(s) is
the Heaviside function: H(s) = 0 if s ≤ 0 and H(s) = 1 if s > 0, σD is a positive constant
representing the threshold value such that in the region where σ > σD nutrient is enough to
sustain (at least a portion of) tumor cells alive and proliferating, whereas in the region where
σ ≤ σD (which may be empty) nutrient is insufficient to sustain any tumor cell alive, f(σ) and
g(σ) are given nutrient consumption rate and tumor cell proliferation rate functions, respectively,
σ¯, β and ν are positive constants representing the nutrient concentration outside the tumor, the
rate of nutrient supply to the tumor, and the dissolution rate of necrotic cells, respectively, and
R0 > 0 is a given initial tumor radius.
Angiogenesis is a complex process in which tumor cells secrete substances that promote the
formation of new blood vessels penetrating into the tumor. In this model, the nutrient enters
the tumor through these new blood vessels and the impact from angiogenesis is incorporated in
the boundary condition (1.3), where the positive constant β reflects the strength of the blood
vessel system of the tumor; the smaller β is, the weaker the blood vessel system of the tumor
will be; β = 0 means that the tumor does not have its own blood vessel system and β = ∞
indicates that the tumor is all surrounded by the blood vessels which reduces to the Dirichlet
boundary condition
σ(R(t), t) = σ¯ for t > 0. (1.6)
Thus, from biological viewpoint, the boundary condition (1.3) is more realistic compared with
(1.6). For more discussions please see [7, 8, 13].
Before going to our interest, we prefer to recall some relevant works. The above model with
linear consumption and proliferation rates:
f(σ) = σ, g(σ) = µ(σ − σ˜) (µ > 0, σ˜ > 0) (1.7)
and the Dirichlet boundary condition (1.6), was proposed by Cui [5] as in essence a combination
of two Byrne-Chaplain inhibitor-free and avascular tumor models; see [3] for the nonnecrotic
case and then [4] for its necrotic version. This is made such that both nonnecrotic tumors and
necrotic tumors can be considered in a joint way. By delicate calculations based on the existence
of an explicit form for solutions of (1.1), (1.2), (1.6), (1.7) for given R(t), Cui [5] studied the
existence, uniqueness and global asymptotic stability of stationary solutions, the dependence
on the parameters ν and σ¯, as well as the mutual transition between the nonnecrotic and
necrotic phases. Recently, Wu and Wang [9] extended the results to the case of general nonlinear
functions f and g. Since no explicit solution is available, they investigated much more profound
relations between all unknown functions. For a broader discussion on the proliferation rate in the
nonnecrotic case, we refer the reader to [2]. More recently, Wu and Xu [10] further established
similar results for the nonlinear model with a periodic external nutrient supply, that is
σ(R(t), t) = φ(t) for t > 0,
where φ(t) is a positive periodic function. For the analysis of other related tumor models, see
[1, 6, 12] for example. When replacing the Dirichlet boundary condition (1.6) with the Robin
condition (1.3), the model (1.1)-(1.5) with linear functions (1.7) was recently studied by Xu and
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Su [11]. As for nonlinear functions f and g, the nonnecrotic case was analyzed by Zhuang and
Cui [13].
Motivated by the above works, in this paper we aim at studying the problem (1.1)-(1.5) with
nonlinear f , g and the Robin boundary condition, and revealing the dependence of solutions on
the parameter σ¯. It should be pointed out that σ¯ rather than other model parameters is chosen
as the dependent parameter, because we think it is extrinsic for tumors. As in [9] we assume
(A1) f ∈ C1[0,+∞), f ′ is positive and bounded on [0,+∞), and f(0) = 0;
(A2) g ∈ C1[0,+∞), g′ ≥ 0 on [0,+∞) and does not identically equal zero in any interval,
and g(σ˜) = 0 for some σ˜ > 0;
(A3) σD < min{σ˜, σ¯} and g(σD) + ν ≥ 0.
Here the relation g(σD) + ν ≥ 0 means that the volume loss rate of living cells at σD is not
greater than the dissolution rate of necrotic cells (see [5] for the detailed derivation).
Based on the above assumptions, it is shown that there exist two thresholds on σ¯: σ˜ and σ∗
(see (2.48)). Indeed, if σ¯ ≤ σ˜, then the problem (1.1)-(1.5) admits no stationary solution and
all evolutionary tumors will finally vanish; if σ¯ > σ˜, then (1.1)-(1.5) admits a unique stationary
solution and all evolutionary tumors will converge to this dormant tumor; moreover, the dormant
tumor is nonnecrotic if σ˜ < σ¯ ≤ σ∗ and necrotic if σ¯ > σ∗ (see Theorems 2.1 and 3.1). Besides,
it is found that mutual transition may exist between the nonnecrotic and necrotic phases in
the growth of tumors (see Theorem 3.2). The biological implication of these results is that
the existence, structure (nonnecrotic or necrotic) and stability of dormant tumor state can be
controlled by external nutrient concentration.
For the nonlinear problem, the analysis of stationary solutions was usually made by first
transforming the free boundary problem into an equivalent problem with fixed boundary and
then investigating this fixed boundary problem. However, some new difficulties being differ-
ent from those encountered in the Dirichlet boundary condition problem arise when we tackle
the Robin boundary condition problem. For example, the maximum principle may not work
sometimes. Inspired by [13], we solve it by employing the relationship between the transformed
function and its original function, and applying the maximum principle to an auxiliary problem;
see the proof of (2.25).
The rest of the paper is organized as follows. In Section 2, we establish the existence and
uniqueness of stationary solutions to the problem (1.1)-(1.5). In Section 3, we prove the global
existence and asymptotic behavior of transient solutions, and present the connection and mutual
transition between the nonnecrotic and necrotic phases.
2 Stationary solutions
In this section, we study stationary solutions to the system (1.1)-(1.5), denoted by (σs(r), Rs),
which satisfy
σ′′(r) +
2
r
σ′(r) = f(σ)H(σ − σD) for 0 < r < R, (2.1)
σ′(0) = 0, (2.2)
σ′(R) + β(σ(R) − σ¯) = 0, (2.3)
3
1R3
[∫
σ>σD
g(σ(r))r2 dr −
∫
σ≤σD
νr2 dr
]
= 0. (2.4)
To be more specific, if the dormant tumor has a necrotic core with radius ρ ∈ (0, R), then the
problem (2.1)-(2.4) becomes
σ′′(r) +
2
r
σ′(r) = f(σ) for ρ < r < R, (2.5)
σ′(ρ) = 0, σ′(R) + β(σ(R)− σ¯) = 0, (2.6)
σ(r) = σD for 0 ≤ r ≤ ρ, (2.7)
1
R3
[∫ R
ρ
g(σ(r))r2 dr −
ν
3
ρ3
]
= 0, (2.8)
whereas if the dormant tumor does not have a necrotic core, then (2.1)-(2.4) reduces to
σ′′(r) +
2
r
σ′(r) = f(σ) for 0 < r < R, (2.9)
σ′(0) = 0, σ(0) ≥ σD, (2.10)
σ′(R) + β(σ(R) − σ¯) = 0, (2.11)
1
R3
∫ R
0
g(σ(r))r2 dr = 0. (2.12)
For any given R > 0, setting s = r
R
, η = ρ
R
and u(s) = σ(r), (2.5) and (2.6) are transformed
into
u′′(s) +
2
s
u′(s) = R2f(u) for η < s < 1, (2.13)
u′(η) = 0, u′(1) + βR(u(1) − σ¯) = 0. (2.14)
Lemma 2.1. Let the assumptions (A1) and (A3) hold. Then for any R > 0 and any 0 ≤ η < 1,
the problem (2.13), (2.14) allows a unique solution u(s) = U(s, η,R). Moreover,
(i) for η ≤ s ≤ 1,
0 < U(s, η,R) < σ¯; (2.15)
(ii) for η < s ≤ 1,
0 <
∂U
∂s
(s, η,R) ≤
sR2f(U(s, η,R))
3
(2.16)
and
1
s
∂U
∂s
(s, η,R) ≤
∂2U
∂s2
(s, η,R); (2.17)
(iii) U(s, η,R) is strictly decreasing in R for η ≤ s ≤ 1, and
lim
R→0+
U(s, η,R) = σ¯ (2.18)
uniformly with respect to s on [η, 1],
lim
R→+∞
U(s, η,R) = 0 (2.19)
uniformly with respect to s on each closed interval contained in [η, 1).
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Proof. Using the assumption (A1), it is easy to see that for any R > 0 and any 0 ≤ η < 1,
the constant functions u(s) ≡ 0 and u¯(s) ≡ σ¯ are sub- and supersolutions of the problem (2.13),
(2.14), respectively. Thus, by the method of sub- and supersolutions, there exists at least one
solution u(s) = U(s, η,R) to this problem satisfying
0 ≤ U(s, η,R) ≤ σ¯ for all η ≤ s ≤ 1, (2.20)
while the uniqueness follows from the maximum principle. Moreover, the uniqueness of solutions
to the initial value problem implies that
U(η, η,R) > 0. (2.21)
Integrating (2.13) yields
∂U
∂s
(s, η,R) =
R2
s2
∫ s
η
l2f(U(l, η,R)) dl for η < s ≤ 1, (2.22)
which together with (2.20) and the hypothesis (A1) gives
∂U
∂s
(s, η,R) ≥ 0 for η < s ≤ 1. (2.23)
(2.16) is then an immediate consequence of (2.21)-(2.23) and (A1). In particular, ∂U
∂s
(1, η,R) > 0.
In view of the second boundary condition in (2.14), we have U(1, η,R) < σ¯; hence, the assertion
(i) is proved. The relation (2.17) can be easily derived from (2.13) and (2.16). Using (2.22) and
L’Hospital’ rule, we further compute
∂2U
∂s2
(η, η,R) = lim
s→η+
∂U
∂s
(s, η,R)
s− η
= lim
s→η+
R2
∫ s
η
l2f(U(l, η,R)) dl
s2(s− η)
=
{
R2
3 f(U(η, η,R)) if η = 0,
R2f(U(η, η,R)) if 0 < η < 1.
(2.24)
We now show that
∂U
∂R
(s, η,R) < 0 for every η ≤ s ≤ 1. (2.25)
First, we assume η ∈ (0, 1). Then U(s, η,R) = σ(r, ρ,R) with r = sR, ρ = ηR, and
∂U
∂R
(s, η,R) = s
∂σ
∂r
(r, ρ,R) + η
∂σ
∂ρ
(r, ρ,R) +
∂σ
∂R
(r, ρ,R). (2.26)
In what follows, for notational simplicity we also denote ∂z
∂r
(r, ρ,R) = zr(r, ρ,R) = z
′(r, ρ,R),
∂2z
∂r2
(r, ρ,R) = zrr(r, ρ,R) = z
′′(r, ρ,R) for a function of three variables z(r, ρ,R). A simple
calculation based on (2.5), (2.6) yields

σ′′R(r, ρ,R) +
2
r
σ′R(r, ρ,R) = f
′(σ(r, ρ,R))σR(r, ρ,R) for ρ < r < R,
σ′R(ρ, ρ,R) = 0,
σ′R(R, ρ,R) + βσR(R, ρ,R) = −σ
′′(R, ρ,R)− βσ′(R, ρ,R),
(2.27)
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

σ′′ρ(r, ρ,R) +
2
r
σ′ρ(r, ρ,R) = f
′(σ(r, ρ,R))σρ(r, ρ,R) for ρ < r < R,
σ′ρ(ρ, ρ,R) = −σ
′′(ρ, ρ,R),
σ′ρ(R, ρ,R) + βσρ(R, ρ,R) = 0
(2.28)
and

σ′′r (r, ρ,R) +
2
r
σ′r(r, ρ,R) = f
′(σ(r, ρ,R))σr(r, ρ,R) +
2
r2
σ′(r, ρ,R) for ρ < r < R,
σ′r(ρ, ρ,R) = σ
′′(ρ, ρ,R),
σ′r(R, ρ,R) + βσr(R, ρ,R) = σ
′′(R, ρ,R) + βσ′(R, ρ,R).
(2.29)
Since it follows from (2.16), (2.17) and (2.24) that
σ′(r, ρ,R) =
1
R
∂U
∂s
(s, η,R) > 0 for ρ < r ≤ R, (2.30)
σ′′(r, ρ,R) =
1
R2
∂2U
∂s2
(s, η,R) > 0 for ρ ≤ r ≤ R,
applying the strong maximum principle we obtain
σR(r, ρ,R) < 0, σρ(r, ρ,R) > 0 for ρ ≤ r ≤ R. (2.31)
Let
Σ(r, ρ,R) = σr(r, ρ,R) + σρ(r, ρ,R) + σR(r, ρ,R).
Then we deduce from (2.27)-(2.29) that

Σ′′(r, ρ,R) + 2
r
Σ′(r, ρ,R) = f ′(σ(r, ρ,R))Σ(r, ρ,R) + 2
r2
σ′(r, ρ,R) for ρ < r < R,
Σ′(ρ, ρ,R) = 0,
Σ′(R, ρ,R) + βΣ(R, ρ,R) = 0.
(2.32)
Using the strong maximum principle again, we get
Σ(r, ρ,R) < 0 for ρ ≤ r ≤ R. (2.33)
Combining (2.26), (2.30), (2.31) and (2.33), we conclude (2.25). Next, if η = 0, then U(s, 0, R) =
σ(r, 0, R) and (2.25) can be verified in a similar manner.
It remains to prove (2.18) and (2.19). By (2.22) and the second boundary condition in (2.14),
we have for any s ∈ [η, 1],
σ¯ − U(s, η,R) =
1
βR
∂U
∂s
(1, η,R) +R2
∫ 1
s
1
τ2
∫ τ
η
l2f(U(l, η,R)) dl dτ, (2.34)
which combined with (2.15) and (2.16) gives
max
s∈[η,1]
|U(s, η,R)− σ¯| ≤
R
3β
f(σ¯) +R2
∫ 1
η
1
τ2
∫ τ
η
l2f(σ¯) dl dτ. (2.35)
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Hence our sending R → 0+ in (2.35) yields (2.18). On the other hand, it follows from (2.34)
that
0 ≤
∫ 1
η
1
τ2
∫ τ
η
l2f(U(l, η,R)) dl dτ ≤
σ¯
R2
.
Letting R→ +∞, by Lebesgue’s dominated convergence theorem we obtain∫ 1
η
1
τ2
∫ τ
η
l2f
(
lim
R→+∞
U(l, η,R)
)
dl dτ = 0.
In view of (A1), we arrive at limR→+∞ U(s, η,R) = 0, a.e. s ∈ (η, 1). The monotonicity of
U(s, η,R) with respect to s further implies (2.19). The proof is complete.
Remark 2.1. We may not be able to expect limR→+∞ U(1, η,R) = 0. As a matter of fact, in
the typical case where f(u) = u, we compute
U(s, η,R) =
C
s
[ηR cosh((s − η)R) + sinh((s− η)R)] for η ≤ s ≤ 1
with
C =
βσ¯(
ηR− 1
R
+ β
)
sinh((1− η)R) + (1− η + βηR) cosh((1 − η)R)
,
which satisfies
lim
R→+∞
U(1, η,R) =
βσ¯
β + 1
> 0.
Define
F (η,R) = U(η, η,R) − σD for 0 ≤ η < 1, R > 0. (2.36)
Then by virtue of (A3) and the assertion (iii) of Lemma 2.1, for each 0 ≤ η < 1, there exists a
unique R = R(η) > 0 such that F (η,R) = 0. In particular, we denote R(0) by Rc. Furthermore,
one obtains from (2.25) and (2.31) that
R′(η) =
Uη(η, η,R(η))
−UR(η, η,R(η))
=
R(η)σρ(ηR(η), ηR(η), R(η))
−UR(η, η,R(η))
> 0 for any 0 < η < 1, (2.37)
which implies that R(η) is strictly increasing on [0, 1). While the next lemma states that the
equation F (η,R) = 0 also uniquely determines a function η of R, whose domain is [Rc,+∞).
Lemma 2.2. Suppose (A1), (A3) are satisfied. Then the following assertions hold:
(i) For each R ≥ Rc, there exists a unique η = η(R) ∈ [0, 1) such that F (η,R) = 0.
(ii) The mapping R 7→ η(R) is strictly increasing, and
lim
R→+∞
η(R) = 1. (2.38)
(iii) For any 0 < R < Rc and 0 ≤ η < 1, F (η,R) > 0.
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Proof. (i) We begin by showing the existence. Evidently, F (0, Rc) = 0 and F (0, R) < 0 for
R > Rc. Since (2.22) and (2.34) imply
U(η, η,R) = σ¯ −
R
β
∫ 1
η
l2f(U(l, η,R)) dl −R2
∫ 1
η
1
τ2
∫ τ
η
l2f(U(l, η,R)) dl dτ for all η ∈ [0, 1),
(2.39)
we see from (2.15) and (A3) that
lim
η→1−
F (η,R) = σ¯ − σD > 0.
Thus, by the continuity of F (η,R) we derive that for fixed R > Rc, there exists at least one
η ∈ (0, 1) such that F (η,R) = 0. Next, the uniqueness follows fromR(η) being strictly monotone.
(ii) In view of (2.37), η′(R) > 0 for all R > Rc; thus, η(R) is strictly increasing on [Rc,+∞)
and limR→+∞ η(R) exists. By (2.39), we have
σ¯ − σD =
R
β
∫ 1
η(R)
l2f(U(l, η(R), R)) dl +R2
∫ 1
η(R)
1
τ2
∫ τ
η(R)
l2f(U(l, η(R), R)) dl dτ
≥
R
β
f(σD)
∫ 1
η(R)
l2 dl.
(2.40)
Hence, sending R→ +∞ in (2.40) yields (2.38).
(iii) Noticing that R(η) ≥ Rc for each η ∈ [0, 1) and U(η, η,R) is strictly decreasing in R, we
immediately arrive at
U(η, η,R) > U(η, η,Rc) ≥ U(η, η,R(η)) = σD for all η ∈ [0, 1) and R ∈ (0, Rc),
which proves the assertion (iii) and completes the proof of the lemma.
Given R > 0, by the uniqueness of solutions of the problem (2.1)-(2.3), we see from Lemmas
2.1 and 2.2 that the solution of (2.1)-(2.3), denoted by σ(r,R), is as follows: if 0 < R ≤ Rc,
then
σ(r,R) = U
( r
R
, 0, R
)
for 0 ≤ r ≤ R, (2.41)
and if R > Rc, then
σ(r,R) =
{
U
(
r
R
, η(R), R
)
if ρ(R) < r ≤ R,
σD if 0 ≤ r ≤ ρ(R),
(2.42)
where ρ(R) = η(R)R.
Remark 2.2. (2.41) and (2.42) imply that if the tumor radius R ≤ Rc (Rc depends on σ¯, σD
and β), then the tumor is nonnecrotic, and if R > Rc then the tumor is necrotic.
Remark 2.3. It is shown in [13, Lemma 2.1] that the function σ(r,R) given by (2.41) has the
following properties:
0 ≤ σr(r,R) ≤ f(σ¯)
r
3
, −f(σ¯)
(
1
β
+
R
3
)
≤ σR(r,R) ≤ 0 (2.43)
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for all R > 0 and 0 ≤ r ≤ R, and
1
r
σr(r,R) ≤ σrr(r,R) ≤ f(σ¯) (2.44)
for all R > 0 and 0 < r ≤ R. In fact, one can further obtain σr(r,R) > 0 for all R > 0 and
r > 0, and if we denote M = supσ≥0 f
′(σ), then a simple calculation based on the assumption
(A1) yields
σ(r,R) ≤ σ(R,R)e
M
6
(r2−R2) (2.45)
for all R > 0 and r > R. Similarly, for the function σ(r,R) given by (2.42) we also have (2.43)
and (2.44) for all R > Rc and ρ(R) ≤ r ≤ R, (2.45) for all R > Rc and r > R.
Substituting (2.41) or (2.42) into (2.4), we obtain the equation for the dormant tumor radius
Rs:
G(R) = 0, (2.46)
where
G(R) =
{∫ 1
0 g(U(s, 0, R))s
2 ds if 0 < R ≤ Rc,∫ 1
η(R) g(U(s, η(R), R))s
2 ds− ν3η
3(R) if R > Rc.
(2.47)
Lemma 2.3. Assume that (A1)-(A3) hold. Then the function G(R) defined by (2.47) possesses
the following properties:
(i) G(R) is continuous and strictly decreasing on (0,+∞).
(ii)
lim
R→0+
G(R) =
g(σ¯)
3
, lim
R→+∞
G(R) = −
ν
3
.
(iii) If Rc is regarded as a function of σ¯, then there exists a number σ
∗ > σ˜ such that
G(Rc(σ¯))


> 0 if σ¯ > σ∗,
= 0 if σ¯ = σ∗,
< 0 if σD < σ¯ < σ
∗.
(2.48)
Proof. It is easy to see that G(R) is continuous on (0,+∞). By (2.25) and the assumption
(A2), we find for 0 < R < Rc,
G′(R) =
∫ 1
0
g′(U(s, 0, R))
∂U
∂R
(s, 0, R)s2 ds < 0.
When R > Rc, we write U(s, η(R), R) as V (s,R), or equivalently, V (s,R) = σ(r,R) for R > Rc
and η(R) ≤ s ≤ 1, where σ(r,R) is given by (2.42). Then an argument similar to that used in
obtaining (2.25) yields
∂V
∂R
(η(R), R) = 0,
∂V
∂R
(s,R) < 0 for η(R) < s ≤ 1. (2.49)
Consequently, a combination of (2.49), the assumptions (A2) and (A3) leads to
G′(R) =
∫ 1
η(R)
g′(V (s,R))
∂V
∂R
(s,R)s2 ds− [g(σD) + ν]η
2(R)η′(R) < 0 for R > Rc.
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The assertion (i) is thus proved. The assertion (ii) immediately follows from (2.18) and (2.38).
We now proceed with the proof of the assertion (iii). Let Rc = Rc(σ¯) for σ¯ > σD and write
W (s, σ¯) = U(s, 0, Rc(σ¯)), G(σ¯) = G(Rc(σ¯)) =
∫ 1
0
g(W (s, σ¯))s2 ds.
Then there holds
R′c(σ¯) > 0 for σ¯ > σD. (2.50)
In fact, setting σ(r, σ¯) =W (s, σ¯) with r = sRc(σ¯), we deduce from (2.9)-(2.11) that

∂2σ
∂r2
(r, σ¯) + 2
r
∂σ
∂r
(r, σ¯) = f(σ(r, σ¯)) for 0 < r < Rc(σ¯),
∂σ
∂r
(0, σ¯) = 0, σ(0, σ¯) = σD,
∂σ
∂r
(Rc(σ¯), σ¯) + β[σ(Rc(σ¯), σ¯)− σ¯] = 0.
(2.51)
Differentiating (2.51) with respect to σ¯ and by the uniqueness of solutions to the initial value
problem, we arrive at
∂σ
∂σ¯
(r, σ¯) ≡ 0 for every 0 ≤ r ≤ Rc(σ¯)
and
R′c(σ¯) =
β
∂2σ
∂r2
(Rc(σ¯), σ¯) + β
∂σ
∂r
(Rc(σ¯), σ¯)
> 0,
which proves (2.50). Furthermore,
∂W
∂σ¯
(s, σ¯) = sR′c(σ¯)
∂σ
∂r
(r, σ¯) +
∂σ
∂σ¯
(r, σ¯) = sR′c(σ¯)
∂σ
∂r
(r, σ¯) > 0 (2.52)
for 0 < s ≤ 1, which implies
G′(σ¯) =
∫ 1
0
g′(W (s, σ¯))
∂W
∂σ¯
(s, σ¯)s2 ds > 0 for σ¯ > σD. (2.53)
From (2.15) and (A2) we see G(σ˜) < 0. On the other hand, since
∂W
∂s
(s, σ¯) =
1
s2
∫ s
0
R2c(σ¯)l
2f(W (l, σ¯)) dl for 0 < s ≤ 1,
recalling that M = supσ≥0 f
′(σ), using (A1) we derive
1
3
R2c(σ¯)f(σD)s ≤
∂W
∂s
(s, σ¯) ≤
M
3
R2c(σ¯)sW (s, σ¯) for 0 ≤ s ≤ 1. (2.54)
As a result,
σD +
1
6
R2c(σ¯)f(σD)s
2 ≤W (s, σ¯) ≤ σDe
M
6
R2c(σ¯)s
2
for all 0 ≤ s ≤ 1. (2.55)
Making use of (2.54), (2.55) and the relation
βσ¯ =
1
Rc(σ¯)
∂W
∂s
(1, σ¯) + βW (1, σ¯),
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we obtain
lim
σ¯→σ+
D
Rc(σ¯) = 0, lim
σ¯→+∞
Rc(σ¯) = +∞,
which in turn leads to
lim
σ¯→+∞
W (s, σ¯) = +∞ for 0 < s ≤ 1. (2.56)
Based on (A2) and (2.52), Levi’s theorem gives
lim
σ¯→+∞
∫ 1
0
[g(W (s, σ¯))− g(σD)]s
2 ds =
∫ 1
0
lim
σ¯→+∞
[g(W (s, σ¯))− g(σD)]s
2 ds.
Hence, it follows from (2.56) and (A2) that
lim
σ¯→+∞
G(σ¯) =
∫ 1
0
lim
σ¯→+∞
g(W (s, σ¯))s2 ds > 0.
We therefore conclude the assertion (iii) by (2.53) and complete the proof of the lemma.
Now we are ready to state the main result of this section.
Theorem 2.1. Let (A1)-(A3) hold. Then the system (1.1)-(1.5) admits a unique stationary
solution (σs(r), Rs) if and only if σ¯ > σ˜. If σ¯ > σ˜, then Rs is the unique positive root of the
equation (2.46), and σs(r) = σ(r,Rs) defined by (2.41) or (2.42). Furthermore, there exists
a positive number σ∗ > σ˜ such that if σ¯ > σ∗, then Rs > Rc, σs(r) is given by (2.42), and
accordingly, the dormant tumor has a necrotic core with radius ρ(Rs), while if σ˜ < σ¯ ≤ σ
∗, then
Rs ≤ Rc, σs(r) is given by (2.41), and the dormant tumor does not have a necrotic core.
3 Transient solutions
In this section, we study transient solutions of the problem (1.1)-(1.5). The first result
concerns the global existence and asymptotic behavior of transient solutions.
Theorem 3.1. Let the assumptions (A1)-(A3) be satisfied. Then for any R0 > 0, the prob-
lem (1.1)-(1.5) has a unique solution (σ(r, t), R(t)) (R(t) > 0, 0 ≤ r ≤ R(t)) for all t > 0.
Moreover, if σ¯ ≤ σ˜, then limt→+∞R(t) = 0, while if σ¯ > σ˜, then limt→+∞R(t) = Rs and
limt→+∞max0≤r≤R(t) |σ(r, t) − σs(r)| = 0.
Proof. Given R(t) > 0, we know from Section 2 that (1.1)-(1.3) admits a unique solution
σ(r,R(t)) (see (2.41), (2.42)). Then by (1.4) and (1.5), R(t) can be determined by solving the
following initial value problem for a first order ordinary differential equation{
R′(t) = R(t)G(R(t)) for t > 0,
R(0) = R0,
(3.1)
where the function G is given by (2.47). The assertions (i), (ii) of Lemma 2.3 imply that for any
R0 > 0, the problem (3.1) has a unique solution R(t) satisfying
R0e
−
ν
3
t ≤ R(t) ≤ R0e
g(σ¯)
3
t for every t ≥ 0. (3.2)
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Accordingly, (1.1)-(1.5) has a unique solution (σ(r, t), R(t)) = (σ(r,R(t)), R(t)) for all t ≥ 0.
If σ¯ < σ˜, then g(σ¯) < 0 and limt→+∞R(t) = 0 immediately follows from (3.2). If σ¯ = σ˜,
then G < 0 on (0,+∞) by the assertions (i), (ii) of Lemma 2.3, and thus R′(t) < 0 for t > 0. We
argue by contradiction and suppose that limt→+∞R(t) = L for some L ∈ (0, R0). Then R(t) ≤
R0e
G(L)t for t ≥ 0, reaching a contradiction. Finally, if σ¯ > σ˜, then G(Rs) = 0. Using this and
the fact that G(R) is strictly decreasing on (0,+∞), we can similarly obtain limt→+∞R(t) = Rs,
which together with Remark 2.3 gives limt→+∞max0≤r≤R(t) |σ(r, t) − σs(r)| = 0. The proof is
complete.
The next result suggests that mutual transition may exist between the nonnecrotic and
necrotic phases in the growth of tumors.
Theorem 3.2. Assume that (A1)-(A3) are fulfilled. Then the following conclusions hold.
(i) Let σ˜ < σ¯ < σ∗. If R0 ≤ Rc, then the tumor is in the nonnecrotic phase for all t ≥ 0,
while if R0 > Rc, then there exists a finite number T > 0 such that the tumor is in the necrotic
phase for 0 ≤ t < T , and in the nonnecrotic phase for t ≥ T .
(ii) Let σ¯ > σ∗. If R0 < Rc, then there exists a finite number T > 0 such that the tumor is
in the nonnecrotic phase for 0 ≤ t ≤ T , and in the necrotic phase for t > T , while if R0 ≥ Rc,
then the tumor is in the necrotic phase for all t > 0.
The proof of Theorem 3.2 relies essentially on the following four facts: an evolutionary tumor
is in the nonnecrotic phase if its radius R(t) ≤ Rc and in the necrotic phase if R(t) > Rc, ensured
by Remark 2.2; an evolutionary tumor converges to the dormant tumor when σ¯ > σ˜ ensured by
Theorem 3.1; the dormant tumor is nonnecrotic and its radius Rs < Rc if σ˜ < σ¯ < σ
∗, whereas
the dormant tumor is necrotic and Rs > Rc if σ¯ > σ
∗, ensured by Theorem 2.1; the function
G in the evolution equation (3.1) is strictly decreasing on (0,+∞) ensured by Lemma 2.3. The
details are omitted for brevity.
Remark 3.1. Theorem 3.2 can be interpreted in the biological context as follows. If the dormant
tumor is nonnecrotic, then an initially small tumor will always be nonnecrotic and an initially
large tumor will be nonnecrotic from a finite time; if the dormant tumor has a necrotic core,
then an initially small tumor will form a necrotic core at a finite time, and an initially large
tumor will always have a necrotic core.
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